Tandem Control-IQ—Now Authorized For Children
Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology…
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)
At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the…
The Importance of Dexcom CLARITY: From Telemedicine to Ultra Marathons
Elite T1D Athlete Eric Tozer and Dexcom Certified Diabetes Educator (CDE) Cher Pastore discuss Dexcom CLARITY technology.
Severe hypoglycemia: Be prepared, not afraid
Fear of Hypoglycemia is a real thing. Learn how you and your loved ones with T1D can overcome it.
ADA’s Scientific Sessions: Day 4
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
FreeStyle Libre 2 Authorized for Use in the U.S.
On June 15, 2020, Abbott announced that the FDA has authorized the FreeStyle Libre 2 System. The Libre 2 gained…
University of Michigan Establishes Elizabeth Weiser Caswell Diabetes Institute
Named for Breakthrough T1D Research Committee member Elizabeth Caswell, Institute will support diabetes research and development of life-changing diabetes therapies.
ADA’s Scientific Sessions: Day 3
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
Updates from the Teplizumab Trial: You’re Not Going to Believe the Results
Last year, at the American Association for Diabetes (ADA) Scientific Sessions, a drug, called teplizumab, was able to significantly delay—for…
ADA’s Scientific Sessions: Day 2
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics,…
